Tricor, Fenofibrate News

Background: The ACCORD-Lipid Trial's finding that statin-fibrate combination therapy provides no incremental cardiovascular risk reduction in type 2 diabetese over statin monotherapy prompted FDA to issue a public communication on 11/9/2011 stating that fenofibrate may not reduce risk of heart attack or stroke.

Lupin's headline numbers appear to be weak, but adjusting for a one-time tax on unrealised profits on inventory sold to overseas subsidiaries and forex losses the adjusted PAT of Rs2.35bn is in line with our expectation, although slightly lower than consensus estimate.

Abbott Laboratories has announced that it will split in two by the end of 2012. One half will be a diversified medical products company, while the other will be a research-based pharmaceutical companies.

A second experimental cholesterol medicine in a once-promising class of drugs meant to replace blockbusters such as Lipitor has failed in testing, casting doubt on whether any of the drugs will ever make it to pharmacies.

Dyslipidemia is common in chronic hemodialysis patients and its underlying mechanism is complex.

Q: My triglyceride level was 419 and my doctor recommended that I take the drug Tricor to lower it.

NEW YORK &#8212 Shares of Irish drugmaker Amarin Corp. rose Monday after a Citi Investment Research analyst began covering the stock with a "Buy" rating, saying U.S. sales of the company's triglyceride drug AMR101 could reach $2.6 billion per year.